russ2000_2_0044|AQST|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
russ2000_2_0044|AQST|1|Aquestive Therapeutics Inc Total Current Assets (Quarterly) (USD)|Aquestive Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Aquestive Therapeutics Inc Inventories (Quarterly) (USD)|Aquestive Therapeutics Inc Net PP&E (Quarterly) (USD)|Aquestive Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Aquestive Therapeutics Inc Total Liabilities (Quarterly) (USD)|Aquestive Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Aquestive Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Aquestive Therapeutics Inc Total Deposits (Quarterly) (USD)|Aquestive Therapeutics Inc Book Value (Quarterly) (USD)|Aquestive Therapeutics Inc Retained Earnings (Quarterly) (USD)|Aquestive Therapeutics Inc Treasury Stock (Quarterly) (USD)|Aquestive Therapeutics Inc EV to Revenues|Aquestive Therapeutics Inc EV to Earnings|Aquestive Therapeutics Inc EV to Free Cash Flow|Aquestive Therapeutics Inc EV to Assets (Quarterly)|Aquestive Therapeutics Inc PS Ratio|Aquestive Therapeutics Inc PE Ratio|Aquestive Therapeutics Inc Price to Book Value|Aquestive Therapeutics Inc PEG Ratio|Aquestive Therapeutics Inc Debt to Equity Ratio|Aquestive Therapeutics Inc Dividend Yield|Aquestive Therapeutics Inc Shareholder Yield (TTM)|Aquestive Therapeutics Inc Percent of Shares Outstanding Short|Aquestive Therapeutics Inc Total Receivables (Quarterly) (USD)|Aquestive Therapeutics Inc Total Payables (Quarterly) (USD)|Aquestive Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Aquestive Therapeutics Inc Return on Invested Capital|Aquestive Therapeutics Inc Quality Ratio Score|Aquestive Therapeutics Inc Momentum Score|Aquestive Therapeutics Inc Beta (1Y)|Aquestive Therapeutics Inc Sustainable Growth Rate (TTM)|Aquestive Therapeutics Inc Institutional Investor Ownership Percentage|Aquestive Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Aquestive Therapeutics Inc Total Employees (Annual)|Aquestive Therapeutics Inc EPS Diluted (Quarterly) (USD)|Aquestive Therapeutics Inc Shares Outstanding|Aquestive Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Aquestive Therapeutics Inc Ordinary Shares Number (Quarterly)|Aquestive Therapeutics Inc Payout Ratio|Aquestive Therapeutics Inc Quick Ratio (Quarterly)|Aquestive Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Aquestive Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Aquestive Therapeutics Inc Effective Tax Rate (TTM)|Aquestive Therapeutics Inc Return on Equity|Aquestive Therapeutics Inc Net Income (TTM) (USD)|Aquestive Therapeutics Inc Revenue (TTM) (USD)|Aquestive Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Aquestive Therapeutics Inc Revenue (Quarterly) (USD)|Aquestive Therapeutics Inc Gross Profit (Quarterly) (USD)|Aquestive Therapeutics Inc SG&A Expense (Quarterly) (USD)|Aquestive Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Aquestive Therapeutics Inc Net Income (Quarterly) (USD)|Aquestive Therapeutics Inc Net Interest Income (Quarterly) (USD)|Aquestive Therapeutics Inc Price (USD)|Aquestive Therapeutics Inc Total Return Price (USD)|Aquestive Therapeutics Inc Enterprise Value (USD)|Aquestive Therapeutics Inc 30-Day Average Daily Volume|Aquestive Therapeutics Inc 1 Year Price Returns (Daily)||
russ2000_2_0044|AQST|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
russ2000_2_0044|AQST|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|daily|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
russ2000_2_0044|AQST|5|91.2|91.2|91.2|91.2|91.2|91.2|91.2|91.2||91.2|91.2||1.44035087719|91.2857142857|1.44035087719|91.2857142857|1.44035087719||1.45528455285|1.44444444444|91.2|1.44797178131|91.2857142857|15.2307692308|91.2|91.2|91.2|91.375|91.375|30.4615384615|30.5||30.5|91.3076923077|320|91.3076923077|30.9166666667||91.2|91.2|91.2|91.3076923077|91.3333333333|91.3333333333||91.2|91.2||91.3076923077|91.3076923077|91.3076923077|91.3076923077|91.3076923077|91.3076923077|1.44797178131|1.44797178131|1.44035087719|1.44795539033|1.44303797468||
russ2000_2_0044|AQST|6|10|10|10|10|10|10|10|10||10|10||570|7|570|7|570||123|315|10|567|7|52|10|10|10|8|8|13|14||14|13|2|13|24||10|10|10|13|9|9||10|10||13|13|13|13|13|13|567|567|570|538|316||
russ2000_2_0044|AQST|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
russ2000_2_0044|AQST|201703||||||||||||||||||||||||||||||||||20||-0.1035||||||-0.0825|||||||16.436|12.252|6.128|-1.457|-1.457|-1.818|||||||
russ2000_2_0044|AQST|201706||||||||||||||||||||||||||||||||||20||-0.3256||||||-0.3004|||||||11.142|6.001|5.223|-5.897|-5.897|-1.949|||||||
russ2000_2_0044|AQST|201709||||||||||||||||||||||||||||||||||20||0.3912||||||0.4225|||||||27.146|22.266|6.161|8.451|8.451|-1.97|||||||
russ2000_2_0044|AQST|201712|28.163|17.379|4.014|13.46|0.254|69.611|15.35|54.261||-107.366|-120.093||||||||||-1.7176||||6.179|9.973|80.871|||||||20||-0.5333|||24||1.5347|-0.4613||||-8.943|66.919||12.195|6.58|7.565|-10.04|-10.04|-1.97|||||||
russ2000_2_0044|AQST|201803|30.421|16.488|3.85|12.764|0.241|68.902|23.472|45.43||-22.82|-23.201||||||||||-2.0142||||9.441|10.989|0.02|||||||20|195|0.2049|||24||1.1047|0.1701||||-3.387|73.894||23.411|17.775|7.569|4.099|4.099|-1.903|||||||
russ2000_2_0044|AQST|201806|26.649|10.638|4.348|12.766|0.229|78.789|23.474|55.315||-38.948|-32.394||5.2722||49.867||4.1189||||-1.1921|||0.0065|6.629|18.526|0.02|-205.3808|10|||||24||-1.5205|24.5||24||0.7356|-1.4431||||-33.983|76.68||13.928|8.955|33.668|-36.493|-36.493|-1.927|15.04|15.04|404.272|||18.01|
russ2000_2_0044|AQST|201809|77.359|63.982|4.483|12.211|0.216|66.566|21.329|45.237||23.444|-47.432||6.6808|-7.3002|-22.0705|4.6613|6.1093||16.0969||1.9964||-17.8768|0.588|7.45|14.376|0.025|-191.7539|8|||||23.6462||-0.64|24.9422||24.9422||3.3491|-0.4659|-68.714|||-57.472|62.801||13.267|7.675|12.346|-15.038|-15.038|-1.717|17.51|17.51|419.5599|165265.5667||15.13|8.59
russ2000_2_0044|AQST|201812|74.201|60.599|5.441|12.207|0.204|76.771|32.952|43.819||10.08|-61.376||2.1331|-2.3435|-9.7087|1.6561|2.1615||15.5983|-0.0074|4.6828||-49.7806|1.1475|6.481|23.339|0.025|-173.2122|10|||||24.8955|277|-0.56|24.9573||24.9573||2.0357|-0.56|-0.116|||-61.376|67.43||16.824|12.037|18.71|-13.944|-13.944|-1.588|6.3|6.3|143.835|165767.2333||6.13|8.05
russ2000_2_0044|AQST|201903|55.958|39.934|5.137|11.594|0.191|74.035|29.638|44.397||-6.056|-78.954||3.1809|-2.2473|-5.3968|2.6513|2.9727||17.1208|-0.0015|-7.8587||-40.1251|1.6819|7.489|19.501|0.025|-200.8097|8|||||24.9636||-0.59|24.9751||24.9751||1.6001|-0.59||||-80.201|56.662||12.643|9.137|17.908|-14.726|-14.726|-1.652|6.91|6.91|180.2359|125259.2333||5.71|3.72
russ2000_2_0044|AQST|201906|39.064|22.165|4.647|10.933|0.178|75.065|24.629|50.436||-24.657|-99.426||2.4203|-2.0312|-2.5786|2.5862|1.9199|||-0.0165|-1.9238||-65.7725|3.7578|10.15|20.21|0.025|-160.9925|9|1|2.046||66.9441|24.9809||-0.82|25.0227||25.0227||1.3121|-0.82||||-64.18|53.863||11.129|5.709|16.246|-20.472|-20.472|-1.784|4.2|4.2|130.3643|154569.8333|-77.3271|3.41|3.8
russ2000_2_0044|AQST|201909|38.06|20.914|4.124|10.351|0.165|83.277|20.053|63.224||-34.459|-117.838||2.2352|-1.7541|-2.2143|2.4273|1.4977|||-0.1321|-1.7347||-3.4971|1.3|10.316|14.497|0.025|-155.5397|8|1|1.6354||62.9948|25.0315||-0.74|25.043||25.043||1.5574|-0.5444||||-67.554|53.014||12.418|7.775|13.714|-18.412|-18.412|-2.514|3.18|3.18|118.4977|120882.1|-81.8389|3.84|7.79
russ2000_2_0044|AQST|201912|68.314|49.326|2.859|9.726|0.153|84.601|18.555|66.046||-6.122|-130.474||3.9223|-3.1149|-3.3898|2.6293|2.8051|||-0.4866|-9.8559||-21.5136|1.2696|13.13|12.574|0.034|-164.6862|9|4|2.8998||81.6332|26.4477|232|-0.48|33.5629||33.5629||3.366|-0.48|-39.317|||-66.246|52.609||16.419|9.627|16.474|-12.636|-12.636|-2.732|5.82|5.82|206.3481|1540692.7667|-7.619|4.05|3.73
russ2000_2_0044|AQST|202003|51.088|35.521|3.087|12.971|0.14|85.316|15.362|69.954||-20.829|-147.004||2.0305|-1.454|-1.7486|1.5344|1.2362|||-0.1898|-2.9249||-57.1897|5.0774|9.536|10.653|0.034|-184.9808|8|2|2.9626||54.0333|33.5697||-0.49|33.5827||33.5827||2.933|-0.49||||-68.05|48.731||8.765|5.106|14.613|-16.53|-16.53|-2.669|2.19|2.19|98.9471|528724.4333|-68.3068|4.31|4.87
russ2000_2_0044|AQST|202006|43.909|25.422|3.173|12.221|0.127|84.934|14.882|70.052||-21.388|-149.338||3.3649|-3.9962|-4.0362|3.1388|2.4317||||-2.8757||-25.7684|5.0974|12.891|8.787|0.034|-136.731|10|9|4.6992||74.1744|33.5892||-0.07|33.6166||33.6166||2.5745|-0.07||||-49.912|59.277||21.675|18.136|13.894|-2.334|-2.334|-2.729|4.86|4.86|199.4597|1202660.7667|15.7143|5.26|7.86
russ2000_2_0044|AQST|202009|||||||||||||3.3623||-4.0331||2.4292|||||||5.5816||||||9|4.9951||74.5167||||||||||||||||||||||4.855|4.855|199.3071|1419829.9|52.673|5.26|